Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 40.89
-0.56 (-1.35%)
May 20, 2026, 11:29 AM CST
SHA:600211 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 967.36 | 937.93 | 1,051 | 800.91 | 369.84 | 208.94 |
Depreciation & Amortization | 78.34 | 78.34 | 75.2 | 68.05 | 69.24 | 81.45 |
Other Amortization | 2.06 | 2.06 | 0.64 | 1.01 | 1.55 | 0.68 |
Loss (Gain) From Sale of Assets | -0.11 | -0.11 | -1.96 | -0.34 | 0.23 | 0.04 |
Asset Writedown & Restructuring Costs | 0.03 | 0.03 | 0.07 | 190.38 | 218.62 | 458.19 |
Loss (Gain) From Sale of Investments | -4.15 | -4.15 | 3.88 | 170.09 | 7.14 | -146.47 |
Provision & Write-off of Bad Debts | -0.4 | -0.4 | 0.6 | 0.04 | -0.51 | -1.39 |
Other Operating Activities | 29.34 | -14.87 | -12.63 | -5.68 | 81.94 | 15.93 |
Change in Accounts Receivable | -195.42 | -195.42 | 98.83 | -237.89 | 22.82 | -317.1 |
Change in Inventory | -43.3 | -43.3 | -22.56 | -16.56 | -18.87 | -67.2 |
Change in Accounts Payable | 225.41 | 225.41 | -163.73 | 147.4 | 38.73 | 164.85 |
Change in Other Net Operating Assets | 0.37 | 0.37 | 2.02 | 1.87 | 52.43 | -1.62 |
Operating Cash Flow | 1,078 | 1,005 | 994.79 | 1,063 | 837.38 | 366.53 |
Operating Cash Flow Growth | 24.18% | 1.00% | -6.45% | 26.99% | 128.46% | -14.39% |
Capital Expenditures | -14.35 | -15.96 | -37.6 | -21.69 | -101.96 | -425.58 |
Sale of Property, Plant & Equipment | 0.35 | 0.34 | 2.78 | 0.54 | 0.11 | 16.78 |
Cash Acquisitions | 162.48 | 162.48 | - | - | - | - |
Investment in Securities | -832.77 | -757.91 | 367.91 | -829.46 | -471.69 | -334.97 |
Other Investing Activities | 21.02 | 21.97 | 21.39 | 18.72 | 12.3 | 2.97 |
Investing Cash Flow | -663.27 | -589.07 | 354.49 | -831.88 | -561.25 | -740.8 |
Short-Term Debt Issued | - | 980.11 | 533.5 | 699.51 | 485.73 | - |
Long-Term Debt Issued | - | - | - | - | - | 576.54 |
Total Debt Issued | 1,046 | 980.11 | 533.5 | 699.51 | 485.73 | 576.54 |
Short-Term Debt Repaid | - | -502.19 | -760.97 | -685.73 | -534.27 | - |
Long-Term Debt Repaid | - | -1.03 | -0.93 | -1.65 | -3.56 | -56.08 |
Total Debt Repaid | -553.23 | -503.22 | -761.9 | -687.39 | -537.82 | -56.08 |
Net Debt Issued (Repaid) | 492.91 | 476.89 | -228.4 | 12.13 | -52.09 | 520.46 |
Common Dividends Paid | -528.89 | -613.53 | -504.05 | -494.47 | -98.18 | -132.49 |
Other Financing Activities | -147.15 | 14.02 | -0.54 | -1.34 | 4.9 | -11.3 |
Financing Cash Flow | -183.13 | -122.62 | -732.99 | -483.69 | -145.37 | 376.67 |
Foreign Exchange Rate Adjustments | -42.19 | -22.45 | 7.44 | 7.04 | 40.11 | -14.42 |
Net Cash Flow | 189.81 | 270.6 | 623.72 | -245.11 | 170.87 | -12.02 |
Free Cash Flow | 1,064 | 988.79 | 957.19 | 1,042 | 735.41 | -59.05 |
Free Cash Flow Growth | 28.58% | 3.30% | -8.12% | 41.65% | - | - |
Free Cash Flow Margin | 35.55% | 33.16% | 34.10% | 33.24% | 28.79% | -2.76% |
Free Cash Flow Per Share | 3.30 | 3.07 | 2.97 | 3.23 | 2.28 | -0.18 |
Cash Income Tax Paid | 392.38 | 392.38 | 500.59 | 443.23 | 272.41 | 274.84 |
Levered Free Cash Flow | 702.31 | 697.85 | 483.26 | 585.86 | 456.08 | -60.38 |
Unlevered Free Cash Flow | 717.68 | 705.72 | 489.19 | 593.11 | 465.06 | -57.68 |
Change in Working Capital | 5.92 | 5.92 | -122.3 | -161.05 | 89.34 | -250.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.